Pro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapy
Open Access
- 20 May 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 30 (6) , 892-898
Abstract
The diagnosis and treatment decisions in glomerular disease are principally based on renal pathology and nonspecific clinical laboratory measurements such as serum creatinine and urine protein. Using these classification approaches, patients have marked variability in rate of progression and response to therapy, exposing a significant number of patients to toxicity without benefit. Additionally, clinical trials are at risk of not being able to detect an efficacious therapy in relevant subgroups as patients with shared clinical-pathologic diagnoses have heterogeneous underlying pathobiology. To change this treatment paradigm, biomarkers that reflect the molecular mechanisms underlying the clinical-pathologic diagnoses are needed. Recent progress to identify such biomarkers has been aided by advances in molecular profiling, large-scale data generation and multi-scalar data integration, including prospectively collected clinical data. This article reviews the evolving success stories in glomerular disease biomarkers across the genotype-phenotype continuum and highlights opportunities to transition to precision medicine in glomerular disease.Keywords
This publication has 53 references indexed in Scilit:
- Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT)BMC Nephrology, 2013
- Epidemiology and Pathophysiology of Nephrotic Syndrome–Associated Thromboembolic DiseaseClinical Journal of the American Society of Nephrology, 2012
- Performance of a Genetic Risk Score for CKD Stage 3 in the General PopulationAmerican Journal of Kidney Diseases, 2012
- Focal Segmental GlomerulosclerosisNew England Journal of Medicine, 2011
- Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Adult Cardiac SurgeryJournal of the American Society of Nephrology, 2011
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort studyBMC Nephrology, 2010
- Chronic Renal Insufficiency Cohort (CRIC) StudyClinical Journal of the American Society of Nephrology, 2009
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- Multiple loci associated with indices of renal function and chronic kidney diseaseNature Genetics, 2009